Excess body fat, particularly abdominal fat, is a major contributor to insulin resistance; therefore, GLP-1 receptor agonists might help increase the body’s sensitivity to insulin, potentially mitigating or even reversing the effects of insulin resistance. This evidence concerns the gene INS and Insulin resistance.